查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1375949

糖组学市场规模、份额和趋势分析报告：按产品、应用、最终用途、地区和细分市场进行预测，2023-2030 年

Glycomics Market Size, Share & Trends Analysis Report By Product (Enzymes, Kits, Reagents, Instruments), By Application (Drug Discovery & Development, Diagnostics), By End Use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10个工作天内

价格

糖组学市场成长与趋势：

Grand View Research, Inc.的最新报告显示，到2030年，全球糖组学市场规模预计将达到49.2亿美元。

2023-2030年年复合成长率预计为14.6%。由于糖组学在各种生物过程中的重要作用，其研究和开发的扩展预计将推动全球市场的发展。此外，对个人化医疗的需求不断增长，进一步推动了行业成长，因为糖组学在基于聚醣的诊断解决方案的开发中发挥关键作用。

最近，醣组学在识别疾病特异性聚醣生物标记以早期检测和诊断各种健康状况方面显示出前景。聚醣生物标记的潜力引起了医疗保健和诊断行业的兴趣。例如，2021 年 11 月，GlycoPath Inc. 推出了一款聚醣成像盒，用于临床和研究样本的糖蛋白组分析。新推出的套件具有从组织成像到生物流体分析的应用范围，并且可以轻鬆适应多种类型的平台。

技术的进步也促进了对糖组学设备的高需求。蛋白质表征等研究已发展成为化学和生化研究中的质谱 (MS)、高效液相层析(HPLC) 和毛细管电泳 (CE) 等先进技术。这些先进技术可提供快速、准确的结果。目前可用的糖组学技术是标准化和简化的。

此外，支持聚醣研究的研究机构数量不断增加是预计在不久的将来推动市场成长的主要因素。国家生物医学糖组学中心 (NCBG) 致力于分析基因组学技术和工具的普及和开发。该中心的分析技术研究和开发项目正在开发聚醣工具、聚醣复合物和资讯学。此外，国家癌症中心由糖生物学家癌症研究联盟组成，旨在研究聚醣的结构和功能以用于癌症研究，这就是我的意思。

糖组学市场报告亮点

  • 由于酵素在基于聚醣的研究、诊断和药物研发中的广泛应用，到 2022 年，酶细分市场将以 29.2% 的收益占有率占据行业主导地位。
  • 药物研发和药物开发是市场上最大的应用，由于行业参与者对开发基于聚醣的诊断的兴趣日益浓厚，诊断领域预计将增长最快。
  • 在最终用途领域，学术和研究机构领域以 38.2% 的收益占有率主导市场。收益的高成长归因于研究中心广泛采用聚醣结构资料分析以及出于培训和教育目的对糖组学的日益偏好。
  • 2022年，北美地区以39.1%的收益占有率主导全球市场。该地区的高成长是由大量研究机构的存在和政府支持法律等因素推动的。

目录

第1章调查方法和范围

第2章执行摘要

第3章市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19感染疾病的影响分析

第4章产品业务分析

  • 糖组学市场：产品变异分析
  • 酵素
    • 酵素市场，2018-2030
    • 糖苷酶
    • 糖基转移酶
    • 神经氨酸酶
    • 唾液酸转移酶
    • 其他的
  • 成套工具
    • 套件市场，2018-2030
    • 聚醣标记试剂盒
    • 聚醣精製盒
    • 聚醣释放套件
    • 其他灰色漫画套件
  • 试剂
    • 2018-2030年试剂市场
    • 糖蛋白
    • 单醣
    • 寡糖
    • 其他试剂
  • 装置
    • 2018-2030年设备市场
    • 质谱仪
    • HPLC
    • MALDI-TOF
    • 阵列系统
    • 其他的

第5章按应用分类的业务分析

  • 糖组学市场：应用变化分析
  • 药物研发发现与开发
  • 诊断
  • 其他的

第6章最终用途的业务分析

  • 糖组学市场：最终用途变异分析
  • 製药和生物技术公司
    • 製药和生物技术公司市场，2018-2030
  • 学术研究所
    • 学术研究机构市场，2018-2030
  • 生物製药公司
    • 2018-2030年生物製药公司市场
  • CRO
    • CRO市场，2018-2030

第7章区域业务分析

  • 2022 年和 2030 年糖组学市场占有率（按地区）
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第8章竞争形势

  • 公司分类
  • 策略规划
  • 2022 年公司市场占有率/地位分析
  • 公司简介/名单
    • Thermo Fisher Scientific, Inc
    • Merck KGaA
    • Agilent Technologies Inc.
    • Bruker
    • New England Biolabs
    • Shimadzu Corporation
    • Waters Corporation
    • Takara Bio Inc
    • Asparia Glycomics
    • RayBiotech Life, Inc.
Product Code: GVR-1-68038-452-9

Glycomics Market Growth & Trends:

The global glycomics market size is expected to reach USD 4.92 billion by 2030, according to a new report by Grand View Research, Inc.. The market is estimated to register a CAGR of 14.6% during 2023-2030. Growing research and development in the glycomics space, owing to its crucial role in various biological processes, is projected to drive the global market. Moreover, the increasing demand for personalized medicine has further supported industry growth as glycomics plays a significant role in developing glycan-based diagnostic solutions.

Recently glycomics have shown promise in identifying disease-specific glycan biomarkers for early detection and diagnosis of various health conditions. The potential for glycan biomarkers has attracted interest from the healthcare and diagnostics industries. For instance, in November 2021 GlycoPath Inc. launched its glycan imaging kit for glycoproteomic analysis of clinical and research samples. The newly launched kit is applicable for tissue imaging to biofluid profiling and is easily adaptable with many kinds of platforms.

Technological advancements have also contributed to the high demand for glycomics instruments. Procedures such as protein characterizations are evolving into advanced technologies such as Mass Spectrometry (MS), High-Performance Liquid Chromatography (HPLC), and Capillary Electrophoresis (CE) in chemical and biochemical research. These advanced techniques provide rapid and precise results. Glycomics technologies currently available are standardized and streamlined.

Furthermore, the increase in the number of research institutes that support glycan-based research is a major factor anticipated to fuel market growth in the near future. The National Center for Biomedical Glycomics (NCBG) focuses on the dissemination & development of technologies and tools for analytical genomics. The organization's analytical, technical R&D program involves the development of glycan tools, glycoconjugate, and informatics. In addition, the National Cancer Institute consists of the Alliance of Glycobiologists for Cancer Research, which aims at studying the structure as well as functions of glycans for cancer study.

Glycomics Market Report Highlights:

  • Enzymes segment dominated the industry in 2022 with a revenue share of 29.2% and is attributed to the wide application of enzymes in glycan-based studies, diagnostics, and drug discovery
  • Drug discovery and development is the largest application of the market, whereas the diagnostics segment is expected to witness the fastest growth owing to the growing interest of industry players in developing glycan-based diagnostics
  • In the end-use segment, the academic & research institutes segment dominated the market with a revenue share of 38.2%. The higher revenue growth is attributed to the extensive adoption of glycan structure data analysis by research centers and the increasing preference for glycomics for training & educational purposes
  • North America region dominated the global market in 2022 with a revenue share of 39.1%. The high growth of the region is governed by factors such as the presence of a large number of research institutes and supportive government legislation.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definition
      • 1.1.1.1. Product Segment
      • 1.1.1.2. Application Segment
      • 1.1.1.3. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objective
    • 1.4.1. Objective 1
    • 1.4.2. Objective 2
    • 1.4.3. Objective 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing focus on glycomics and proteomics research
      • 3.2.1.2. Rising R & D investments by pharmaceutical and biotechnology companies
      • 3.2.1.3. Technological advancements
      • 3.2.1.4. Increasing focus on developing alternative to animal testing
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of glycomics instruments
      • 3.2.2.2. Stringent government policies and regulations
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Glycomics Market: Product Movement Analysis
  • 4.2. Enzymes
    • 4.2.1. Enzymes Market, 2018 - 2030 (USD Million)
    • 4.2.2. Glycosidases
      • 4.2.2.1. Glycosidases Market, 2018 - 2030 (USD Million)
    • 4.2.3. Glycosyltransferases
      • 4.2.3.1. Glycosyltransferases Market, 2018 - 2030 (USD Million)
    • 4.2.4. Neuraminidases
      • 4.2.4.1. Neuraminidases Market, 2018 - 2030 (USD Million)
    • 4.2.5. Sialyltransferases
      • 4.2.5.1. Sialyltransferases Market, 2018 - 2030 (USD Million)
    • 4.2.6. Others
      • 4.2.6.1. Others Market, 2018 - 2030 (USD Million)
  • 4.3. Kits
    • 4.3.1. Kits Market, 2018 - 2030 (USD Million)
    • 4.3.2. Glycan labeling kits
      • 4.3.2.1. Glycan labeling kits Market, 2018 - 2030 (USD Million)
    • 4.3.3. Glycan purification kits
      • 4.3.3.1. Glycan purification kits Market, 2018 - 2030 (USD Million)
    • 4.3.4. Glycan release kits
      • 4.3.4.1. Glycan release kits Market, 2018 - 2030 (USD Million)
    • 4.3.5. Other glycomics kits
      • 4.3.5.1. Other glycomics kits Market, 2018 - 2030 (USD Million)
  • 4.4. Reagents
    • 4.4.1. Reagents Market, 2018 - 2030 (USD Million)
    • 4.4.2. Glycoproteins
      • 4.4.2.1. Glycoproteins Market, 2018 - 2030 (USD Million)
    • 4.4.3. Monosaccharides
      • 4.4.3.1. Monosaccharides Market, 2018 - 2030 (USD Million)
    • 4.4.4. Oligosaccharides
      • 4.4.4.1. Oligosaccharides Market, 2018 - 2030 (USD Million)
    • 4.4.5. Other reagents
      • 4.4.5.1. Other reagents Market, 2018 - 2030 (USD Million)
  • 4.5. Instruments
    • 4.5.1. Instruments Market, 2018 - 2030 (USD Million)
    • 4.5.2. Mass spectrometers
      • 4.5.2.1. Mass spectrometers Market, 2018 - 2030 (USD Million)
    • 4.5.3. HPLC
      • 4.5.3.1. HPLC Market, 2018 - 2030 (USD Million)
    • 4.5.4. MALDI-TOF
      • 4.5.4.1. MALDI-TOF Market, 2018 - 2030 (USD Million)
    • 4.5.5. Array systems
      • 4.5.5.1. Array systems Market, 2018 - 2030 (USD Million)
    • 4.5.6. Others
      • 4.5.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Glycomics Market: Application Movement Analysis
  • 5.2. Drug Discovery & Development
    • 5.2.1. Drug Discovery & Development Market, 2018 - 2030 (USD Million)
  • 5.3. Diagnostics
    • 5.3.1. Diagnostics Market, 2018 - 2030 (USD Million)
  • 5.4. Others
    • 5.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. End Use Business Analysis

  • 6.1. Glycomics Market: End Use Movement Analysis
  • 6.2. Pharmaceutical & Biotechnology Companies
    • 6.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 6.3. Academic & Research Institutes
    • 6.3.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 6.4. Biopharmaceutical Companies
    • 6.4.1. Biopharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • 6.5. CROs
    • 6.5.1. CROs Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Glycomics Market Share By Region, 2022 & 2030
  • 7.2. North America
    • 7.2.1. North America Glycomics Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Target Disease Prevalence
      • 7.2.2.3. Competitive Scenario
      • 7.2.2.4. U.S. Glycomics Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Target Disease Prevalence
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. Canada Glycomics Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Glycomics Market, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Target Disease Prevalence
      • 7.3.2.3. Competitive Scenario
      • 7.3.2.4. UK Glycomics Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Germany Glycomics Market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. France Glycomics Market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Target Disease Prevalence
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. Italy Glycomics Market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Target Disease Prevalence
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Spain Glycomics Market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Target Disease Prevalence
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Denmark Glycomics Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Target Disease Prevalence
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Sweden Glycomics Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Target Disease Prevalence
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Norway Glycomics Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Glycomics Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target Disease Prevalence
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Japan Glycomics Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. China Glycomics Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. India Glycomics Market, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Australia Glycomics Market, 2018 - 2030 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Thailand Glycomics Market, 2018 - 2030 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. South Korea Glycomics Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Glycomics Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target Disease Prevalence
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Brazil Glycomics Market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Mexico Glycomics Market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Argentina Glycomics Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Glycomics Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Target Disease Prevalence
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. South Africa Glycomics Market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Saudi Arabia Glycomics Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. UAE Glycomics Market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Kuwait Glycomics Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share/Position Analysis, 2022
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific, Inc
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Merck KGaA
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Agilent Technologies Inc.
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Bruker
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. New England Biolabs
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Shimadzu Corporation
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Waters Corporation
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Takara Bio Inc
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Asparia Glycomics
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. RayBiotech Life, Inc.
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 List of Abbreviations
  • TABLE 3 Regulatory Framework
  • TABLE 4 Global Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 5 Global Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 6 Global Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 7 Global Glycomics Market, By Region, 2018 - 2030 (USD Million)
  • TABLE 8 North America Glycomics Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 9 North America Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 10 North America Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 11 North America Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 12 U.S. Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 13 U.S. Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 14 U.S. Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 15 Canada Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 16 Canada Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 17 Canada Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 18 Europe Glycomics Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 19 Europe Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 20 Europe Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 21 Europe Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 22 UK Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 23 UK Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 24 UK Glycomics Market, By End-Use, 2018 - 2030 (USD Million),
  • TABLE 25 Germany Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 26 Germany Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 27 Germany Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 28 France Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 29 France Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 30 France Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 31 Spain Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 32 Spain Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 33 Spain Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 34 Italy Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 35 Italy Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 36 Italy Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 37 Denmark Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 38 Denmark Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 39 Denmark Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 40 Norway Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 41 Norway Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 42 Norway Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 43 Sweden Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 44 Sweden Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 45 Sweden Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 46 Asia Pacific Glycomics Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 47 Asia Pacific Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 48 Asia Pacific Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 49 Asia Pacific Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 50 China Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 51 China Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 52 China Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 53 Japan Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 54 Japan Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 55 Japan Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 56 India Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 57 India Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 58 India Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 59 South Korea Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 60 South Korea Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 61 South Korea Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 62 Australia Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 63 Australia Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 64 Australia Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 65 Thailand Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 66 Thailand Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 67 Thailand Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 68 Latin America Glycomics Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 69 Latin America Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 70 Latin America Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 71 Latin America Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 72 Brazil Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 73 Brazil Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 74 Brazil Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 75 Mexico Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 76 Mexico Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 77 Mexico Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 78 Argentina Glycomics Market, By Product, 2018 - 2030 (USD Million),
  • TABLE 79 Argentina Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 80 Argentina Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 81 MEA Glycomics Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 82 MEA Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 83 MEA Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 84 MEA Glycomics Market, By End-Use, 2018 - 2030 (USD Million),
  • TABLE 85 South Africa Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 86 South Africa Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 87 South Africa Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 88 UAE Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 89 UAE Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 90 UAE Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 91 Saudi Arabia Glycomics Market, By Product, 2018 - 2030 (USD Million),
  • TABLE 92 Saudi Arabia Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 93 Saudi Arabia Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 94 Kuwait Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 95 Kuwait Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 96 Kuwait Glycomics Market, By End-Use, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain-based sizing & forecasting
  • FIG. 6 Market formulation & validation
  • FIG. 7 glycomics market segmentation
  • FIG. 8 Market snapshot, 2022
  • FIG. 9 Market trends & outlook
  • FIG. 10 Market driver relevance analysis (current & future impact)
  • FIG. 11 Market restraint relevance analysis (current & future impact)
  • FIG. 12 PESTEL analysis
  • FIG. 13 Porter's five forces analysis
  • FIG. 14 Global glycomics market: Product movement analysis
  • FIG. 15 Global glycomics market, for enzymes, 2018 - 2030 (USD Million)
  • FIG. 16 Global glycomics market, for glycosidases, 2018 - 2030 (USD Million)
  • FIG. 17 Global glycomics market, for glycosyltransferases, 2018 - 2030 (USD Million)
  • FIG. 18 Global glycomics market, for neuraminidases, 2018 - 2030 (USD Million)
  • FIG. 19 Global glycomics market, for sialyltransferases, 2018 - 2030 (USD Million)
  • FIG. 20 Global glycomics market, for others, 2018 - 2030 (USD Million)
  • FIG. 21 Global glycomics market, for kits, 2018 - 2030 (USD Million)
  • FIG. 22 Global glycomics market, for glycan labeling kits, 2018 - 2030 (USD Million)
  • FIG. 23 Global glycomics market, for glycan purification kits, 2018 - 2030 (USD Million)
  • FIG. 24 Global glycomics market, for glycan release kits, 2018 - 2030 (USD Million)
  • FIG. 25 Global glycomics market, for other glycomics kits, 2018 - 2030 (USD Million)
  • FIG. 26 Global glycomics market, for reagents, 2018 - 2030 (USD Million)
  • FIG. 27 Global glycomics market, for glycoproteins, 2018 - 2030 (USD Million)
  • FIG. 28 Global glycomics market, for monosaccharides, 2018 - 2030 (USD Million)
  • FIG. 29 Global glycomics market, for oligosaccharides, 2018 - 2030 (USD Million)
  • FIG. 30 Global glycomics market, for other reagents, 2018 - 2030 (USD Million)
  • FIG. 31 Global glycomics market, for instruments, 2018 - 2030 (USD Million)
  • FIG. 32 Global glycomics market, for mass spectrometers, 2018 - 2030 (USD Million)
  • FIG. 33 Global glycomics market, for HPLC, 2018 - 2030 (USD Million)
  • FIG. 34 Global glycomics market, for MALDI-TOF, 2018 - 2030 (USD Million)
  • FIG. 35 Global glycomics market, for array systems, 2018 - 2030 (USD Million)
  • FIG. 36 Global glycomics market, for others, 2018 - 2030 (USD Million)
  • FIG. 37 Global glycomics market: Application movement analysis
  • FIG. 38 Global glycomics market, for drug discovery & development, 2018 - 2030 (USD Million)
  • FIG. 39 Global glycomics market, for diagnostics, 2018 - 2030 (USD Million)
  • FIG. 40 Global glycomics market, for others, 2018 - 2030 (USD Million)
  • FIG. 41 Global glycomics market: End Use movement analysis
  • FIG. 42 Global glycomics market, for academic & research institutes, 2018 - 2030 (USD Million)
  • FIG. 43 Global glycomics market, for pharmaceutical & biotechnology companies, 2018 - 2030 (USD Million)
  • FIG. 44 Global glycomics market, for biopharmaceutical companies, 2018 - 2030 (USD Million)
  • FIG. 45 Global glycomics market, for CROs, 2018 - 2030 (USD Million)
  • FIG. 46 Regional marketplace: Key takeaways
  • FIG. 47 Regional outlook, 2022 & 2030
  • FIG. 48 Global glycomics market: Region movement analysis
  • FIG. 49 North America glycomics market, 2018 - 2030 (USD Million)
  • FIG. 50 U.S. glycomics market, 2018 - 2030 (USD Million)
  • FIG. 51 Canada glycomics market, 2018 - 2030 (USD Million)
  • FIG. 52 Europe glycomics market, 2018 - 2030 (USD Million)
  • FIG. 53 Germany glycomics market, 2018 - 2030 (USD Million)
  • FIG. 54 UK glycomics market, 2018 - 2030 (USD Million)
  • FIG. 55 France glycomics market, 2018 - 2030 (USD Million)
  • FIG. 56 Italy glycomics market, 2018 - 2030 (USD Million)
  • FIG. 57 Spain glycomics market, 2018 - 2030 (USD Million)
  • FIG. 58 Denmark glycomics market, 2018 - 2030 (USD Million)
  • FIG. 59 Sweden glycomics market, 2018 - 2030 (USD Million)
  • FIG. 60 Norway glycomics market, 2018 - 2030 (USD Million)
  • FIG. 61 Asia Pacific glycomics market, 2018 - 2030 (USD Million)
  • FIG. 62 Japan glycomics market, 2018 - 2030 (USD Million)
  • FIG. 63 China glycomics market, 2018 - 2030 (USD Million)
  • FIG. 64 India glycomics market, 2018 - 2030 (USD Million)
  • FIG. 65 Australia glycomics market, 2018 - 2030 (USD Million)
  • FIG. 66 South Korea glycomics market, 2018 - 2030 (USD Million)
  • FIG. 67 Thailand glycomics market, 2018 - 2030 (USD Million)
  • FIG. 68 Latin America glycomics market, 2018 - 2030 (USD Million)
  • FIG. 69 Brazil glycomics market, 2018 - 2030 (USD Million)
  • FIG. 70 Mexico glycomics market, 2018 - 2030 (USD Million)
  • FIG. 71 Argentina glycomics market, 2018 - 2030 (USD Million)
  • FIG. 72 Middle East and Africa glycomics market, 2018 - 2030 (USD Million)
  • FIG. 73 South Africa glycomics market, 2018 - 2030 (USD Million)
  • FIG. 74 Saudi Arabia glycomics market, 2018 - 2030 (USD Million)
  • FIG. 75 UAE glycomics market, 2018 - 2030 (USD Million)
  • FIG. 76 Kuwait glycomics market, 2018 - 2030 (USD Million)